Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE)
SAFE
1 other identifier
interventional
50
1 country
1
Brief Summary
The objective is to evaluate the effect of a nutritional prevention program associated with the consumption of "Primevère margarine" on the quality of life of women at risk of cardiovascular disease after 10 group coaching sessions in nutrition and physical activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy-volunteers
Started Jul 2023
Typical duration for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 11, 2023
CompletedFirst Submitted
Initial submission to the registry
March 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedApril 23, 2024
April 1, 2024
1.6 years
March 22, 2024
April 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline on quality of life of women with cardiovascular risk at 3 months after a nutritional prevention program associated with the consumption of "Primevère margarine"
Quality of Life Questionnaire Short Form-36 validated by World Health Organization (WHO)
At 3 months after the coaching session
Secondary Outcomes (22)
Change from baseline on life behaviours at 3 months after a nutritional prevention program associated with the consumption of "Primevère margarine"
At 3 months after the coaching session
Change from baseline on well-being at 3 months after a nutritional prevention program associated with the consumption of "Primevère margarine"
At 3 months after the coaching session
Change from baseline on stress management at 3 months after a nutritional prevention program associated with the consumption of "Primevère margarine"
At 3 months after the coaching session
Change from baseline on food behaviors at 3 months after a nutritional prevention program associated with the consumption of "Primevère margarine"
At 3 months after the coaching session
Change from baseline on food behaviors at 3 months after a nutritional prevention program associated with the consumption of "Primevère margarine"
At 3 months after the coaching session
- +17 more secondary outcomes
Study Arms (1)
Nutrional and physical activity program
EXPERIMENTAL10 collective combined workshops of nutrition and physical activity = 1 per week during 10 weeks associated to margarine consumption
Interventions
Nutritional prevention and physical activity workshops associated with a substitution of saturated and/or trans fatty acids by cis-unsaturated acids via the consumption of Primevère margarine to influence lifestyle habits, quality of life and improvement of the lipid profile of women with cardiovascular risk
Eligibility Criteria
You may qualify if:
- BMI \> 25kg/m² and/or with a waist circumference \> 88 cm
- Regularly consuming butter and/or "standard" margarine rich in saturated fatty acids
You may not qualify if:
- Regularly consuming "healthy" margarine enriched with omega 3 (Primevere, St Hubert ω3 ...) or with phytosterols (Pro-active)
- Treated with lipid-lowering agents (statins), antidiabetic or antihypertensive drugs for less than 3 months
- Suffering of eating disorders
- Presenting a medical contraindication to the practice of physical activity
- Having previously participated in a similar prevention program
- Suffering from serious chronic diseases (cancer, serious cardiovascular history, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NutrInvest - Institut Pasteur de Lille
Lille, Nord, 59019, France
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Michel Lecerf, MD
Institut Pasteur de Lille - NutrInvest
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Invesigator
Study Record Dates
First Submitted
March 22, 2024
First Posted
April 23, 2024
Study Start
July 11, 2023
Primary Completion
March 1, 2025
Study Completion
August 1, 2025
Last Updated
April 23, 2024
Record last verified: 2024-04